Stock 2190 ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Zylox-Tonbridge Medical Technology Co., Ltd. Stock

Equities

2190

CNE100004JD2

Medical Equipment, Supplies & Distribution

Delayed Hong Kong S.E.
Other stock markets
 04:08:07 2024-05-09 am EDT 		5-day change 1st Jan Change
10.56 HKD +3.33% Intraday chart for Zylox-Tonbridge Medical Technology Co., Ltd. +0.76% -15.11%
Mar. 22 Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 MT
Mar. 21 Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2023 528M 73.05M 571M Sales 2024 * 764M 106M 826M Capitalization 3.19B 442M 3.46B
Net income 2023 -78M -10.8M -84.37M Net income 2024 * 72M 9.97M 77.88M EV / Sales 2023 7.02 x
Net cash position 2023 * 1.05B 145M 1.13B Net cash position 2024 * 994M 138M 1.07B EV / Sales 2024 * 2.88 x
P/E ratio 2023
-47.1 x
P/E ratio 2024 *
44.3 x
Employees 765
Yield 2023 *
-
Yield 2024 *
-
Free-Float 32.53%
More Fundamentals * Assessed data

Chart Zylox-Tonbridge Medical Technology Co., Ltd.

Dynamic Chart

Latest news about Zylox-Tonbridge Medical Technology Co., Ltd.

Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 MT
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Avinger in Equity Funding Partnership With Chinese Medical Device Firm, Unveils Debt-Terms Extension; Shares Rise Premarket MT
Zylox-Tonbridge Enters Licensing, Investment Contracts with American Innovative Medical Device Maker MT
Avinger, Inc. Announces New Strategic Partnership with Zylox-Tonbridge Medical Technology Co., Ltd CI
Avinger, Inc. announced that it expects to receive $15 million in funding from Zylox-Tonbridge Medical Technology Co., Ltd. CI
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE CI
China Grants Marketing Approval to Zylox-Tonbridge's Peripheral Venous Stent System; Shares Fall 7% MT
Zylox-Tonbridge Medical Technology Co., Ltd Receives Marketing Approval from National Medical Products Administration Grants Marketing for Zylox® Penguin Peripheral Venous Stent System CI
Zylox-Tonbridge Medical Technology Co., Ltd. Announces National Medical Products Administration Grants Marketing Approval for Zylox Phoenix Peripheral Detachable Fibrous Coil Embolization System CI
Zylox Tonbridge Secures Chinese Marketing Approval for Arterial Embolization Device MT
Zylox-Tonbridge Completes Patient Enrolment for Post-Marketing Clinical Trial of Stent System in EU MT
Zylox-Tonbridge Medical Technology Co., Ltd. Completes Enrollment of All 100 Patients in the Multi-Center Clinical Trial in Germany CI
Zylox-Tonbridge Medical Technology Co., Ltd. Receives Official Marketing Approval CI
China Grants Marketing Approval to Zylox-Tonbridge's Balloon Catheter MT
More news

Press releases Zylox-Tonbridge Medical Technology Co., Ltd.

Zylox-Tonbridge was Added to the FTSE Global Equity Index Series PR
Zylox-Tonbridge to be Added to MSCI China All Shares Small Cap Index PR
Zylox-Tonbridge Announces Financial Results for 2022, Revenue Increases by 87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million AQ
Zylox Tonbridge Medical Technology : ANNOUNCEMENT REGARDING COMPLETION OF THE H SHARE FULL CIRCULATION PU
More press releases

Quotes and Performance

1 day+3.33%
1 week+0.76%
Current month+0.76%
1 month+12.70%
3 months+4.35%
6 months-12.00%
Current year-15.11%
More quotes

Highs and lows

1 week
10.20
Extreme 10.2
11.00
1 month
8.62
Extreme 8.62
11.00
Current year
8.62
Extreme 8.62
12.58
1 year
7.20
Extreme 7.2
14.66
3 years
7.20
Extreme 7.2
60.80
5 years
7.20
Extreme 7.2
60.80
10 years
7.20
Extreme 7.2
60.80
More quotes

Managers and Directors - Zylox-Tonbridge Medical Technology Co., Ltd.

Managers TitleAgeSince
Zhong Zhao CEO
 Chief Executive Officer 58 12-11-05
Quan Wei Yuan DFI
 Director of Finance/CFO 46 20-12-31
Ning Pan CTO
 Chief Tech/Sci/R&D Officer 58 18-12-31
Members of the board TitleAgeSince
Hong Ze Liang BRD
 Director/Board Member 53 21-03-01
Yun Qiu BRD
 Director/Board Member 61 21-03-01
Hui Wang BRD
 Director/Board Member 52 15-10-31
More insiders

Quotes

Date Price Change Volume
24-05-09 10.56 +3.33% 108,500
24-05-08 10.22 -4.84% 263,500
24-05-07 10.74 +1.70% 153,000
24-05-06 10.56 -1.12% 191,500
24-05-03 10.68 +1.71% 118,500

Delayed Quote Hong Kong S.E., May 09, 2024 at 04:08 am EDT

More quotes

Company Profile

Zylox-Tonbridge Medical Technology Co Ltd, formerly Zylox Medical Device Co Ltd, is a China-based company mainly engaged in the research and development of neurological and peripheral vascular interventional medical devices. The Company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The Company's products are sold to domestic and foreign markets.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-08-25 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for Zylox-Tonbridge Medical Technology Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
9.756 CNY
Average target price
14.11 CNY
Spread / Average Target
+44.60%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Stock Zylox-Tonbridge Medical Technology Co., Ltd.
-15.11% 428M
STRYKER CORPORATION Stock Stryker Corporation
+10.49% 125B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-7.14% 10.97B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+4.05% 8.99B
GLAUKOS CORPORATION Stock Glaukos Corporation
+35.39% 5.38B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-14.29% 4.86B
AXONICS, INC. Stock Axonics, Inc.
+8.31% 3.43B
ENOVIS CORPORATION Stock Enovis Corporation
-8.87% 2.78B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-4.33% 2.22B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-0.90% 2.21B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. 2190 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW